Market News AIOpen the app

Fortrea has introduced a new tool called FINE to make clinical trials run better by using different data sources.

ProductRead the original at prnewswire.com
Good for FTRE

Fortrea launched a tool to help sponsors plan cardiovascular trials and choose countries and sites. Faster proposals and better choices could help its business, though the company has not reported results from the tool.

FTRE · Fortrea

AI read · Good for FTRE

The AI's read

This gives Fortrea a new tool to help sponsors plan trials. Better estimates of patient numbers and site choices could make study planning more efficient. Faster proposals may also make Fortrea more useful to sponsors. Fortrea has not reported added sales or proven results from FINE. The benefits remain expected, but the stated improvements support a positive read.

Get alerts for FTRE

Follow Fortrea (FTRE) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for FTRE
Free on the App Store and Google Play, or on the web.